Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Thrombospondin-1 (1016-1023) (human, bovine, mouse)

Name
Thrombospondin-1 (1016-1023) (human, bovine, mouse)
Molecular structural formula
Purity
95%
CAS Number
149234-04-8
Formula
C56H81N13O10S1
MW
1128.39
Target
Apoptosis
Sequence
Arg-Phe-Tyr-Val-Val-Met-Trp-Lys
Sequence Shortening
RFYVVMWK
InChIKey
OBPWCMITEMLEAX-MGQPXDLZSA-N
Solubility in water
14.29 mg/mL
References
[1].The C-terminal peptide of thrombospondin-1 stimulates distinct signaling pathways but induces an activation-independent agglutination of platelets and other cells. [2].Platelet aggregation induced by the C-terminal peptide of thrombospondin-1 requires the docking protein LAT but is largely independent of alphaIIb/beta3. [3].Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells. [4]. The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. [5].Thrombospondin-1-Derived Peptide RFYVVMWK Improves the Adhesive Phenotype of CD34 + Cells From Atherosclerotic Patients With Type 2 Diabetes.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

The octapeptide RFYVVMWK constitutes the active sequence within the 30-mer peptide named C₄ as it is essential for the cell attachment activity of the TS1 CBD. It supports the attachment of G361 melanoma cells and inhibits their adhesion to the rec CBD of TS1. Moreover, this peptide appears to be highly conserved in all TS1 isoforms, and a related sequence is also present in the fragment F9 of laminin. 4N1 has been used as CD47 agonist.